GUILLAIN-BARRE SYNDROME
Clinical trials for GUILLAIN-BARRE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new GUILLAIN-BARRE SYNDROME trials appear
Sign up with your email to follow new studies for GUILLAIN-BARRE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for GBS: Single-Dose drug enters final testing
Disease control Recruiting nowThis study tests a single dose of tanruprubart (ANX005) in 30 adults and children with Guillain-Barré syndrome (GBS), a rare nerve disorder that causes weakness. The goal is to see how the drug works in the body, its early effects, and its safety. Participants must have GBS sympt…
Matched conditions: GUILLAIN-BARRE SYNDROME
Phase: PHASE3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Which breathing aid works best for Guillain-Barré? new trial aims to find out
Disease control Recruiting nowThis study tests two breathing support devices—high-velocity nasal cannula (HVNI) and non-invasive ventilation (NIV)—in 80 adults with Guillain-Barré syndrome who have serious breathing trouble. The goal is to see which device helps more patients avoid needing a breathing tube wi…
Matched conditions: GUILLAIN-BARRE SYNDROME
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC